Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Rowe, Steven M

Class:Id	Person:5678891
_displayName	Rowe, Steven M
_timestamp	2015-02-26 18:22:00
created	[InstanceEdit:5678752] Jassal, Bijay, 2015-02-26
firstname	Steven M
initial	SM
surname	Rowe
(author)	[LiteratureReference:5678772] A CFTR potentiator in patients with cystic fibrosis and the G551D mutation [LiteratureReference:5678792] Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation [LiteratureReference:8867582] Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator [LiteratureReference:9700232] Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial [LiteratureReference:9700244] VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles [LiteratureReference:9700265] VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
[Change default viewing format]

No pathways have been reviewed or authored by Rowe, Steven M (5678891)